Albireo Pharma, Inc. (NASDAQ: ALBO) is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders.

This Company Webcast was recorded during the Lytham Partners Spring 2022 Investor Conference.